Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glofitamab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06534437
What this trial is testing

MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Ryvu Therapeutics SA 178
Not applicableLooking for participantsNCT06481826
What this trial is testing

Glofitamab in Chinese Patients With R/R DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07542678
What this trial is testing

Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept

Who this might be right for
Relapsed /Refractory DLBCL
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07711483
What this trial is testing

GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

Who this might be right for
LymphomaB-cell LymphomasRelapsed/Refractory Large B-cell Lymphoma+1 more
Massachusetts General Hospital 56
Large-scale testing (Phase 3)Active Not RecruitingNCT04408638
What this trial is testing

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Hoffmann-La Roche 270
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07387848
What this trial is testing

Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

Who this might be right for
Diffuse Large B Cell Lymphoma Refractory
American University of Beirut Medical Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012980
What this trial is testing

Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Shanghai Zhongshan Hospital 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT06464185
What this trial is testing

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06656221
What this trial is testing

A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Ruijin Hospital 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04889716
What this trial is testing

CAR-T Followed by Bispecific Antibodies

Who this might be right for
Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Abramson Cancer Center at Penn Medicine 23
Early research (Phase 1)Not Yet RecruitingNCT07444710
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell LymphomaAnn Arbor Stage IV Mantle Cell Lymphoma
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07724457
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 RearrangementsRefractory Burkitt Lymphoma+1 more
National Cancer Institute (NCI) 271
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798156
What this trial is testing

Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748364
What this trial is testing

Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

Who this might be right for
Relapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Mantle Cell Lymphoma
Joshua Brody 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07184788
What this trial is testing

G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma

Who this might be right for
Aggressive B-Cell Lymphoma
Navy General Hospital, Beijing 80
Early research (Phase 1)Active Not RecruitingNCT05169515
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Hoffmann-La Roche 121
Testing effectiveness (Phase 2)Looking for participantsNCT05533775
What this trial is testing

Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Mature B-Cell Non-Hodgkin Lymphoma
Hoffmann-La Roche 65
Early research (Phase 1)Temporarily pausedNCT06922604
What this trial is testing

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System LymphomaSecondary Central Nervous System Lymphoma
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05783596
What this trial is testing

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaIndolent Non-hodgkin Lymphoma
Reid Merryman, MD 47
Testing effectiveness (Phase 2)Looking for participantsNCT06043674
What this trial is testing

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

Who this might be right for
Chronic Lymphocytic LeukemiaRichter's Transformation
Christine Ryan 70
Next Page